| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q3 2025 | 8 | 16,369 | OVID, EQ, XLO, STTK | 13F-HR | 11/13/2025 | 000139506425000157 |
| Q2 2025 | 11 | 19,553 | HLVX, OVID, XLO, AMWL | 13F-HR | 8/7/2025 | 000139506425000124 |
| Q1 2025 | 11 | 16,194 | HLVX, OVID, XLO, EQ | 13F-HR | 5/12/2025 | 000139506425000055 |
| Q4 2024 | 11 | 26,564 | HLVX, OVID, XLO, EQ | 13F-HR | 2/12/2025 | 000139506425000019 |
| Q3 2024 | 10 | 37,950 | HLVX, WVE, OVID, STTK | 13F-HR | 2/13/2025 | 000139506425000030 |
| Q2 2024 | 13 | 232,311 | DNLI, HLVX, PHAT, WVE | 13F-HR | 2/13/2025 | 000139506425000028 |
| Q1 2024 | 15 | 289,040 | HLVX, DNLI, PHAT, OVID | 13F-HR | 2/13/2025 | 000139506425000026 |
| Q4 2023 | 14 | 327,499 | HLVX, DNLI, PHAT, OVID | 13F-HR | 2/13/2025 | 000139506425000024 |
Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each security where the latest filing since 12/18/2024 is a 13D, newest first.
| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (1) | ||||||
|
Hillevax, Inc.
13D/A
HLVX · 43157M102
|
0% |
9/19/2025
Event 9/17/2025
|
||||
| Takeda Pharmaceutical Company Limited | 0% | |||||
| Takeda Vaccines Inc. | 0% | |||||
1 other security where the latest filing is a 13G, filed 12/9/2025. View all